Leucémie myéloïde chronique et inhibiteurs de tyrosine kinase = Chronic myelogenous leukemic and tyrosine kinase inhibitorsMAHON, F. X.La Revue de médecine interne (Paris). 2001, Vol 22, Num 9, pp 894-899, issn 0248-8663Article

Leucémie myéloïde chronique = Chronic myeloid leukemiaMAHON, F. X.Correspondances en onco-hématologie. 2012, Vol 7, Num 4, pp 208-211, issn 1954-4820, 4 p.Article

Leucémie myéloïde chronique : Diagnostic, évolution, pronostic = Chronic myeloid leukaemiaMAHON, F.-X; REIFFERS, J.La Revue du praticien (Paris). 1996, Vol 46, Num 18, pp 2231-2234, issn 0035-2640Article

Voies de signalisation: Kinases et inhibiteurs de tyrosine kinases: retour ou continuité ?MAHON, F. X.Correspondances en onco-hématologie. 2012, Vol 7, Num 3, pp 30-34, issn 1954-4820, 5 p., SUP1Article

Leucémie myéloïde chronique : étude critique des essais thérapeutiques de l'interféron-alpha recombinant et analyse des facteurs de pronostic = Chronic myeloid leukemia : critical study of therapeutic trials using interferon and analysis of prognostic factorsREIFFERS, J; MAHON, F.-X.Hématologie (Montrouge). 1999, Vol 5, Num 3, pp 225-232, issn 1264-7527Article

Arrêt du traitement par inhibiteurs de tyrosine-kinase = Stopping treatment with tyrosine-kinase inhibitorsREA, D; MAHON, F.-X.Oncologie (Paris). 2012, Vol 14, Num 10-11, pp 606-608, issn 1292-3818, 3 p.Article

Autologous peripheral blood stem cell transplantation for chronic myelocytic leukaemia, using unmanipulated graftsPIGNEUX, A; MAHON, F. X; REIFFERS, J et al.Baillière's best practice & research. Clinical haematology. 1999, Vol 12, Num 1-2, pp 193-198, issn 1521-6926Article

Correction of the enzyme deficit of bone marrow cells in congenital erythropoietic porphyria by retroviral gene transferMOREAU-GAUDRY, F; BARBOT, C; MAZURIER, F et al.Hematology and cell therapy (Print). 1996, Vol 38, Num 2, pp 217-220, issn 1269-3286Conference Paper

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571 : diverse mechanisms of resistanceMAHON, F. X; DEININGER, M. W. N; SCHULTHEIS, B et al.Blood. 2000, Vol 96, Num 3, pp 1070-1079, issn 0006-4971Article

Rapid analysis and efficient selection of human transduced primitive hematopoietic cells using the humanized S65T green fluorescent proteinMAZURIER, F; MOREAU-GAUDRY, F; DE VERNEUIL, H et al.Gene therapy (Basingstoke). 1998, Vol 5, Num 4, pp 556-562, issn 0969-7128Article

All-trans retinoic acid potentiates the inhibitory effects of interferon α on chronic myeloid leukemia progenitors in vitroMAHON, F. X; CHAHINE, H; BARBOT, C et al.Leukemia. 1997, Vol 11, Num 5, pp 667-673, issn 0887-6924Article

Autografting in chronic myeloid leukemia : an overviewREIFFERS, J; MAHON, F. X; BOIRON, J. M et al.Leukemia. 1996, Vol 10, Num 3, pp 385-388, issn 0887-6924Article

The Effect of Imatinib (Glivec®) on Scleroderma and Normal Dermal Fibroblasts : A Preclinical StudySORIA, A; CARLO-ANDRE, M; LEPREUX, S et al.Dermatology (Basel). 2008, Vol 216, Num 2, pp 109-117, issn 1018-8665, 9 p.Article

Prognosis and prognostic factors for patients with chronic myeloid leukemia: Nontransplant therapyHASFORD, J; PFIRRMANN, M; HEHLMANN, R et al.Seminars in hematology. 2003, Vol 40, Num 1, pp 4-12, issn 0037-1963, 9 p.Article

Increased liposome-mediated gene transfer into haematopoietic cells grown in adhesion to stromal or fibroblast cell line monolayersMARIT, G; YUNXU CAO; REIFFERS, J et al.European journal of haematology. 2000, Vol 64, Num 1, pp 22-31, issn 0902-4441Article

Response to recombinant interferon alpha in patients with chronic myelogenous leukemia in a single center : results and analysis of predictive factorsMONTASTRUC, M; MAHON, F. X; SALMI, R et al.Leukemia. 1995, Vol 9, Num 12, pp 1997-2002, issn 0887-6924Article

Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylateTIPPING, A. J; BALUCH, S; BARNES, D. J et al.Leukemia. 2004, Vol 18, Num 8, pp 1352-1356, issn 0887-6924, 5 p.Article

Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfaMAHON, F. X; DELBREL, X; CONY-MAKHOUL, P et al.Journal of clinical oncology. 2002, Vol 20, Num 1, pp 214-220, issn 0732-183XArticle

Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugsTIPPING, A. J; MAHON, F. X; ZAFIRIDES, G et al.Leukemia. 2002, Vol 16, Num 12, pp 2349-2357, issn 0887-6924, 9 p.Article

Expression of neurotrophins and their receptors in human bone marrowLABOUYRIE, E; DUBUS, P; GROPPI, A et al.The American journal of pathology. 1999, Vol 154, Num 2, pp 405-415, issn 0002-9440Article

Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571TABRIZI, R; MAHON, F. X; MAKHOUL, P. Cony et al.Leukemia. 2002, Vol 16, Num 6, pp 1154-1159, issn 0887-6924Article

Expression of Flt3-ligand by the endothelial cellSOLANILLA, A; GROSSET, C; LEMERCIER, C et al.Leukemia. 2000, Vol 14, Num 1, pp 153-162, issn 0887-6924Article

Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha-interferonREIFFERS, I; TAYLOR, K; GLUCKMAN, E et al.British journal of haematology. 1998, Vol 102, Num 3, pp 639-646, issn 0007-1048Article

Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-αMAHON, F. X; FABERES, C; PIGNEUX, A et al.Blood. 1998, Vol 92, Num 11, pp 4059-4065, issn 0006-4971Article

Evaluation de la radiosensibilité des progéniteurs de leucémie aiguë myéloblastique par des méthodes de culture explorant ou non l'autorenouvellement = Evaluation of the radiosensitivity of acute myeloblastic leukemia progenite cells by culture methods exploring self-renewalCOWEN, D; RICHAUD, P; LANDRIAU, S et al.Bulletin du cancer. Radiothérapie. 1993, Vol 80, Num 2, pp 108-117, issn 0924-4212Article